A perspective of polyamine metabolism
Top Cited Papers
- 15 November 2003
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 376 (1) , 1-14
- https://doi.org/10.1042/bj20031327
Abstract
Polyamines are essential for the growth and function of normal cells. They interact with various macromolecules, both electrostatically and covalently and, as a consequence, have a variety of cellular effects. The complexity of polyamine metabolism and the multitude of compensatory mechanisms that are invoked to maintain polyamine homoeostasis argue that these amines are critical to cell survival. The regulation of polyamine content within cells occurs at several levels, including transcription and translation. In addition, novel features such as the +1 frameshift required for antizyme production and the rapid turnover of several of the enzymes involved in the pathway make the regulation of polyamine metabolism a fascinating subject. The link between polyamine content and human disease is unequivocal, and significant success has been obtained in the treatment of a number of parasitic infections. Targeting the polyamine pathway as a means of treating cancer has met with limited success, although the development of drugs such as DFMO (alpha-difluoromethylornithine), a rationally designed anticancer agent, has revolutionized our understanding of polyamine function in cell growth and provided 'proof of concept' that influencing polyamine metabolism and content within tumour cells will prevent tumour growth. The more recent development of the polyamine analogues has been pivotal in advancing our understanding of the necessity to deplete all three polyamines to induce apoptosis in tumour cells. The current thinking is that the polyamine inhibitors/analogues may also be useful agents in the chemoprevention of cancer and, in this area, we may yet see a revival of DFMO. The future will be in adopting a functional genomics approach to identifying polyamine-regulated genes linked to either carcinogenesis or apoptosis.Keywords
This publication has 95 references indexed in Scilit:
- Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.The Journal of cell biology, 1989
- Oncogenes modulate cellular gene expression and repress glucocorticoid regulated gene transcriptionThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Polyamine Depletion Following Exposure to DL‐α‐Difluoromethylornithine Both In Vivo and In Vitro Initiates Morphological Alterations and Mitochondrial Activation in a Monomorphic Strain of Trypanosoma brucei bruceiThe Journal of Protozoology, 1986
- Factors affecting polyamine excretion from mammalian cells in cultureFEBS Letters, 1986
- Elevation of monoacetylated polyamines in human breast cancersEuropean Journal of Cancer and Clinical Oncology, 1985
- 1-Aminooxy-3-aminopropane, a new and potent inhibitor of polyamine biosynthesis that inhibits ornithine decarboxylase, adenosylmethionine decarboxylase and spermidine synthaseBiochemical and Biophysical Research Communications, 1985
- Reversible inhibition of rat liver regeneration by 1,3‐diamino‐2‐propanol, an inhibitor of ornithine decarboxylaseFEBS Letters, 1978
- Inhibition of ornithine decarboxylase activity and spermidine accumulation in regenerating rat liverBiochemical and Biophysical Research Communications, 1976
- Ornithine decarboxylase activity in germinating conidia of Aspergillus nidulansFEBS Letters, 1975
- Inhibitors of polyamine biosynthesis. 3. (+-)-5-Amino-2-hydrazino-2-methylpentanoic acid, an inhibitor of ornithine decarboxylaseJournal of Medicinal Chemistry, 1975